Product Information
ZONISAMIDE 50 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0955 per EA under NDC 76282022701. Its NADAC has been published 195 times since Jan 11, 2023.
FDA first approved this application on May 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282022701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZONISAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077869FDA Approved
5/31/2006
TE Code
AB
On Market Since
3/15/2021
Pharmacological Classes
Price Statistics
The NADAC for ZONISAMIDE 50 MG CAPSULE has been published 195 times since Jan 11, 2023, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0955 per EA |
|---|---|
| All-time high | $0.1181 (Sep 13, 2023) |
| All-time low | $0.0679 (Jul 17, 2024) |
| 52-week high | $0.0984 |
| 52-week low | $0.0948 |
| Median price | $0.0951 |
| Average price | $0.0927 |
| Largest weekly change | +39.5% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Jan 11, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zonisamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZONISAMIDE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZONISAMIDE 50 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.0955 per EA (NDC 76282022701), effective Sep 30, 2026.
How has the price of ZONISAMIDE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZONISAMIDE 50 MG CAPSULE has risen 4.4%. It has been tracked across 195 weekly CMS publications since Jan 11, 2023.
What are the highest and lowest recorded NADAC prices for ZONISAMIDE 50 MG CAPSULE?
Since Jan 11, 2023, the NADAC for ZONISAMIDE 50 MG CAPSULE has ranged from a low of $0.0679 (Jul 17, 2024) to a high of $0.1181 (Sep 13, 2023), with a median of $0.0951 per EA.
Are there cheaper alternatives to ZONISAMIDE 50 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZONISAMIDE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ZONISAMIDE 50 MG CAPSULE?
ZONISAMIDE 50 MG CAPSULE (NDC 76282022701) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.